Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90


MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma.

Yang H, Cho ME, Li TW, Peng H, Ko KS, Mato JM, Lu SC.

J Clin Invest. 2013 Jan;123(1):285-98. doi: 10.1172/JCI63861. Epub 2012 Dec 17.


Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.

Frau M, Feo F, Pascale RM.

J Hepatol. 2013 Oct;59(4):830-41. doi: 10.1016/j.jhep.2013.04.031. Epub 2013 May 7. Review.


miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.

Zhao N, Sun H, Sun B, Zhu D, Zhao X, Wang Y, Gu Q, Dong X, Liu F, Zhang Y, Li X.

Sci Rep. 2016 Mar 16;6:23091. doi: 10.1038/srep23091.


MicroRNA-21-3p, a berberine-induced miRNA, directly down-regulates human methionine adenosyltransferases 2A and 2B and inhibits hepatoma cell growth.

Lo TF, Tsai WC, Chen ST.

PLoS One. 2013 Sep 30;8(9):e75628. doi: 10.1371/journal.pone.0075628. eCollection 2013.


Forced expression of methionine adenosyltransferase 1A in human hepatoma cells suppresses in vivo tumorigenicity in mice.

Li J, Ramani K, Sun Z, Zee C, Grant EG, Yang H, Xia M, Oh P, Ko K, Mato JM, Lu SC.

Am J Pathol. 2010 May;176(5):2456-66. doi: 10.2353/ajpath.2010.090810. Epub 2010 Apr 2.


Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.

Cao Y, Chen J, Wang D, Peng H, Tan X, Xiong D, Huang A, Tang H.

Oncotarget. 2015 Nov 10;6(35):38093-106. doi: 10.18632/oncotarget.5642.


Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis.

Au SL, Wong CC, Lee JM, Fan DN, Tsang FH, Ng IO, Wong CM.

Hepatology. 2012 Aug;56(2):622-31. doi: 10.1002/hep.25679. Epub 2012 Jun 11.


MicroRNA-122 affects cell aggressiveness and apoptosis by targeting PKM2 in human hepatocellular carcinoma.

Xu Q, Zhang M, Tu J, Pang L, Cai W, Liu X.

Oncol Rep. 2015 Oct;34(4):2054-64. doi: 10.3892/or.2015.4175. Epub 2015 Aug 5.


miR-612 suppresses the invasive-metastatic cascade in hepatocellular carcinoma.

Tao ZH, Wan JL, Zeng LY, Xie L, Sun HC, Qin LX, Wang L, Zhou J, Ren ZG, Li YX, Fan J, Wu WZ.

J Exp Med. 2013 Apr 8;210(4):789-803. doi: 10.1084/jem.20120153. Epub 2013 Mar 11.


miR-208-3p promotes hepatocellular carcinoma cell proliferation and invasion through regulating ARID2 expression.

Yu P, Wu D, You Y, Sun J, Lu L, Tan J, Bie P.

Exp Cell Res. 2015 Aug 15;336(2):232-41. doi: 10.1016/j.yexcr.2015.07.008. Epub 2015 Jul 10.


NF-κB signaling relieves negative regulation by miR-194 in hepatocellular carcinoma by suppressing the transcription factor HNF-1α.

Bao C, Li Y, Huan L, Zhang Y, Zhao F, Wang Q, Liang L, Ding J, Liu L, Chen T, Li J, Yao M, Huang S, He X.

Sci Signal. 2015 Jul 28;8(387):ra75. doi: 10.1126/scisignal.aaa8441.


Double-negative feedback loop between microRNA-422a and forkhead box (FOX)G1/Q1/E1 regulates hepatocellular carcinoma tumor growth and metastasis.

Zhang J, Yang Y, Yang T, Yuan S, Wang R, Pan Z, Yang Y, Huang G, Gu F, Jiang B, Lin C, Zhou W.

Hepatology. 2015 Feb;61(2):561-73. doi: 10.1002/hep.27491.


Thyroid hormone receptor-mediated regulation of the methionine adenosyltransferase 1 gene is associated with cell invasion in hepatoma cell lines.

Wu SM, Huang YH, Lu YH, Chien LF, Yeh CT, Tsai MM, Liao CH, Chen WJ, Liao CJ, Cheng WL, Lin KH.

Cell Mol Life Sci. 2010 Jun;67(11):1831-43. doi: 10.1007/s00018-010-0281-2. Epub 2010 Feb 10.


ANT2 suppression by shRNA restores miR-636 expression, thereby downregulating Ras and inhibiting tumorigenesis of hepatocellular carcinoma.

Jang JY, Lee YS, Jeon YK, Lee K, Jang JJ, Kim CW.

Exp Mol Med. 2013 Jan 10;45:e3. doi: 10.1038/emm.2013.1.


Upregulation of miR-362-3p Modulates Proliferation and Anchorage-Independent Growth by Directly Targeting Tob2 in Hepatocellular Carcinoma.

Shen H, Li W, Tian Y, Xu P, Wang H, Zhang J, Li Y.

J Cell Biochem. 2015 Aug;116(8):1563-73. doi: 10.1002/jcb.25110.


Sulfatide epigenetically regulates miR-223 and promotes the migration of human hepatocellular carcinoma cells.

Dong YW, Wang R, Cai QQ, Qi B, Wu W, Zhang YH, Wu XZ.

J Hepatol. 2014 Apr;60(4):792-801. doi: 10.1016/j.jhep.2013.12.004. Epub 2013 Dec 11.


Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progression.

Frau M, Tomasi ML, Simile MM, Demartis MI, Salis F, Latte G, Calvisi DF, Seddaiu MA, Daino L, Feo CF, Brozzetti S, Solinas G, Yamashita S, Ushijima T, Feo F, Pascale RM.

Hepatology. 2012 Jul;56(1):165-75. doi: 10.1002/hep.25643. Epub 2012 Jun 5.


MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma.

Wang W, Zhao LJ, Tan YX, Ren H, Qi ZT.

Carcinogenesis. 2012 May;33(5):1113-20. doi: 10.1093/carcin/bgs113. Epub 2012 Feb 23.


MiRNA-192 [corrected] and miRNA-204 Directly Suppress lncRNA HOTTIP and Interrupt GLS1-Mediated Glutaminolysis in Hepatocellular Carcinoma.

Ge Y, Yan X, Jin Y, Yang X, Yu X, Zhou L, Han S, Yuan Q, Yang M.

PLoS Genet. 2015 Dec 28;11(12):e1005726. doi: 10.1371/journal.pgen.1005726. eCollection 2015 Dec. Erratum in: PLoS Genet. 2016 Jan;12(1):e1005825.

Supplemental Content

Support Center